Generic Injectable Drugs Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Injectable Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Small Molecule
1.2.3 Large Molecule
1.3 Market by Application
1.3.1 Global Generic Injectable Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Anesthesia
1.3.4 Anti-Infectives
1.3.5 Parenteral Nutrition
1.3.6 Cardiovascular Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Generic Injectable Drugs Market Perspective (2017-2028)
2.2 Generic Injectable Drugs Growth Trends by Region
2.2.1 Generic Injectable Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Generic Injectable Drugs Historic Market Size by Region (2017-2022)
2.2.3 Generic Injectable Drugs Forecasted Market Size by Region (2023-2028)
2.3 Generic Injectable Drugs Market Dynamics
2.3.1 Generic Injectable Drugs Industry Trends
2.3.2 Generic Injectable Drugs Market Drivers
2.3.3 Generic Injectable Drugs Market Challenges
2.3.4 Generic Injectable Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Injectable Drugs Players by Revenue
3.1.1 Global Top Generic Injectable Drugs Players by Revenue (2017-2022)
3.1.2 Global Generic Injectable Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Generic Injectable Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Injectable Drugs Revenue
3.4 Global Generic Injectable Drugs Market Concentration Ratio
3.4.1 Global Generic Injectable Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Injectable Drugs Revenue in 2021
3.5 Generic Injectable Drugs Key Players Head office and Area Served
3.6 Key Players Generic Injectable Drugs Product Solution and Service
3.7 Date of Enter into Generic Injectable Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Injectable Drugs Breakdown Data by Type
4.1 Global Generic Injectable Drugs Historic Market Size by Type (2017-2022)
4.2 Global Generic Injectable Drugs Forecasted Market Size by Type (2023-2028)
5 Generic Injectable Drugs Breakdown Data by Application
5.1 Global Generic Injectable Drugs Historic Market Size by Application (2017-2022)
5.2 Global Generic Injectable Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Generic Injectable Drugs Market Size (2017-2028)
6.2 North America Generic Injectable Drugs Market Size by Type
6.2.1 North America Generic Injectable Drugs Market Size by Type (2017-2022)
6.2.2 North America Generic Injectable Drugs Market Size by Type (2023-2028)
6.2.3 North America Generic Injectable Drugs Market Share by Type (2017-2028)
6.3 North America Generic Injectable Drugs Market Size by Application
6.3.1 North America Generic Injectable Drugs Market Size by Application (2017-2022)
6.3.2 North America Generic Injectable Drugs Market Size by Application (2023-2028)
6.3.3 North America Generic Injectable Drugs Market Share by Application (2017-2028)
6.4 North America Generic Injectable Drugs Market Size by Country
6.4.1 North America Generic Injectable Drugs Market Size by Country (2017-2022)
6.4.2 North America Generic Injectable Drugs Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Generic Injectable Drugs Market Size (2017-2028)
7.2 Europe Generic Injectable Drugs Market Size by Type
7.2.1 Europe Generic Injectable Drugs Market Size by Type (2017-2022)
7.2.2 Europe Generic Injectable Drugs Market Size by Type (2023-2028)
7.2.3 Europe Generic Injectable Drugs Market Share by Type (2017-2028)
7.3 Europe Generic Injectable Drugs Market Size by Application
7.3.1 Europe Generic Injectable Drugs Market Size by Application (2017-2022)
7.3.2 Europe Generic Injectable Drugs Market Size by Application (2023-2028)
7.3.3 Europe Generic Injectable Drugs Market Share by Application (2017-2028)
7.4 Europe Generic Injectable Drugs Market Size by Country
7.4.1 Europe Generic Injectable Drugs Market Size by Country (2017-2022)
7.4.2 Europe Generic Injectable Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Injectable Drugs Market Size (2017-2028)
8.2 Asia-Pacific Generic Injectable Drugs Market Size by Type
8.2.1 Asia-Pacific Generic Injectable Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Generic Injectable Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Generic Injectable Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Generic Injectable Drugs Market Size by Application
8.3.1 Asia-Pacific Generic Injectable Drugs Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Generic Injectable Drugs Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Generic Injectable Drugs Market Share by Application (2017-2028)
8.4 Asia-Pacific Generic Injectable Drugs Market Size by Region
8.4.1 Asia-Pacific Generic Injectable Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Generic Injectable Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Generic Injectable Drugs Market Size (2017-2028)
9.2 Latin America Generic Injectable Drugs Market Size by Type
9.2.1 Latin America Generic Injectable Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Generic Injectable Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Generic Injectable Drugs Market Share by Type (2017-2028)
9.3 Latin America Generic Injectable Drugs Market Size by Application
9.3.1 Latin America Generic Injectable Drugs Market Size by Application (2017-2022)
9.3.2 Latin America Generic Injectable Drugs Market Size by Application (2023-2028)
9.3.3 Latin America Generic Injectable Drugs Market Share by Application (2017-2028)
9.4 Latin America Generic Injectable Drugs Market Size by Country
9.4.1 Latin America Generic Injectable Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Generic Injectable Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Injectable Drugs Market Size (2017-2028)
10.2 Middle East & Africa Generic Injectable Drugs Market Size by Type
10.2.1 Middle East & Africa Generic Injectable Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Generic Injectable Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Generic Injectable Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Generic Injectable Drugs Market Size by Application
10.3.1 Middle East & Africa Generic Injectable Drugs Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Generic Injectable Drugs Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Generic Injectable Drugs Market Share by Application (2017-2028)
10.4 Middle East & Africa Generic Injectable Drugs Market Size by Country
10.4.1 Middle East & Africa Generic Injectable Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Generic Injectable Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Hospira (Pfizer Inc.)
11.1.1 Hospira (Pfizer Inc.) Company Details
11.1.2 Hospira (Pfizer Inc.) Business Overview
11.1.3 Hospira (Pfizer Inc.) Generic Injectable Drugs Introduction
11.1.4 Hospira (Pfizer Inc.) Revenue in Generic Injectable Drugs Business (2017-2022)
11.1.5 Hospira (Pfizer Inc.) Recent Developments
11.2 Fresenius Kabi
11.2.1 Fresenius Kabi Company Details
11.2.2 Fresenius Kabi Business Overview
11.2.3 Fresenius Kabi Generic Injectable Drugs Introduction
11.2.4 Fresenius Kabi Revenue in Generic Injectable Drugs Business (2017-2022)
11.2.5 Fresenius Kabi Recent Developments
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Details
11.3.2 Sandoz (Novartis) Business Overview
11.3.3 Sandoz (Novartis) Generic Injectable Drugs Introduction
11.3.4 Sandoz (Novartis) Revenue in Generic Injectable Drugs Business (2017-2022)
11.3.5 Sandoz (Novartis) Recent Developments
11.4 Hikma Pharmaceuticals PLC
11.4.1 Hikma Pharmaceuticals PLC Company Details
11.4.2 Hikma Pharmaceuticals PLC Business Overview
11.4.3 Hikma Pharmaceuticals PLC Generic Injectable Drugs Introduction
11.4.4 Hikma Pharmaceuticals PLC Revenue in Generic Injectable Drugs Business (2017-2022)
11.4.5 Hikma Pharmaceuticals PLC Recent Developments
11.5 Dr. Reddy?s Laboratories Ltd
11.5.1 Dr. Reddy?s Laboratories Ltd Company Details
11.5.2 Dr. Reddy?s Laboratories Ltd Business Overview
11.5.3 Dr. Reddy?s Laboratories Ltd Generic Injectable Drugs Introduction
11.5.4 Dr. Reddy?s Laboratories Ltd Revenue in Generic Injectable Drugs Business (2017-2022)
11.5.5 Dr. Reddy?s Laboratories Ltd Recent Developments
11.6 Grifols
11.6.1 Grifols Company Details
11.6.2 Grifols Business Overview
11.6.3 Grifols Generic Injectable Drugs Introduction
11.6.4 Grifols Revenue in Generic Injectable Drugs Business (2017-2022)
11.6.5 Grifols Recent Developments
11.7 Nichi-Iko Group (Sagent)
11.7.1 Nichi-Iko Group (Sagent) Company Details
11.7.2 Nichi-Iko Group (Sagent) Business Overview
11.7.3 Nichi-Iko Group (Sagent) Generic Injectable Drugs Introduction
11.7.4 Nichi-Iko Group (Sagent) Revenue in Generic Injectable Drugs Business (2017-2022)
11.7.5 Nichi-Iko Group (Sagent) Recent Developments
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Generic Injectable Drugs Introduction
11.8.4 Teva Pharmaceutical Revenue in Generic Injectable Drugs Business (2017-2022)
11.8.5 Teva Pharmaceutical Recent Developments
11.9 Auromedics
11.9.1 Auromedics Company Details
11.9.2 Auromedics Business Overview
11.9.3 Auromedics Generic Injectable Drugs Introduction
11.9.4 Auromedics Revenue in Generic Injectable Drugs Business (2017-2022)
11.9.5 Auromedics Recent Developments
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Generic Injectable Drugs Introduction
11.10.4 Sanofi Revenue in Generic Injectable Drugs Business (2017-2022)
11.10.5 Sanofi Recent Developments
11.11 Gland Pharma
11.11.1 Gland Pharma Company Details
11.11.2 Gland Pharma Business Overview
11.11.3 Gland Pharma Generic Injectable Drugs Introduction
11.11.4 Gland Pharma Revenue in Generic Injectable Drugs Business (2017-2022)
11.11.5 Gland Pharma Recent Developments
11.12 Endo International PLC
11.12.1 Endo International PLC Company Details
11.12.2 Endo International PLC Business Overview
11.12.3 Endo International PLC Generic Injectable Drugs Introduction
11.12.4 Endo International PLC Revenue in Generic Injectable Drugs Business (2017-2022)
11.12.5 Endo International PLC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Generic Injectable Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Small Molecule
Table 3. Key Players of Large Molecule
Table 4. Global Generic Injectable Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Generic Injectable Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Generic Injectable Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Generic Injectable Drugs Market Share by Region (2017-2022)
Table 8. Global Generic Injectable Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Generic Injectable Drugs Market Share by Region (2023-2028)
Table 10. Generic Injectable Drugs Market Trends
Table 11. Generic Injectable Drugs Market Drivers
Table 12. Generic Injectable Drugs Market Challenges
Table 13. Generic Injectable Drugs Market Restraints
Table 14. Global Generic Injectable Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Generic Injectable Drugs Revenue Share by Players (2017-2022)
Table 16. Global Top Generic Injectable Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectable Drugs as of 2021)
Table 17. Ranking of Global Top Generic Injectable Drugs Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Generic Injectable Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Generic Injectable Drugs Product Solution and Service
Table 21. Date of Enter into Generic Injectable Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Generic Injectable Drugs Revenue Market Share by Type (2017-2022)
Table 25. Global Generic Injectable Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Generic Injectable Drugs Revenue Market Share by Type (2023-2028)
Table 27. Global Generic Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Generic Injectable Drugs Revenue Share by Application (2017-2022)
Table 29. Global Generic Injectable Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Generic Injectable Drugs Revenue Share by Application (2023-2028)
Table 31. North America Generic Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Generic Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Generic Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Generic Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Generic Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Generic Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Generic Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Generic Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Generic Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Generic Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Generic Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Generic Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Generic Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Generic Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Generic Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Generic Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Generic Injectable Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Generic Injectable Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Generic Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Generic Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Generic Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Generic Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Generic Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Generic Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Generic Injectable Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Generic Injectable Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Generic Injectable Drugs Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Generic Injectable Drugs Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Generic Injectable Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Generic Injectable Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 61. Hospira (Pfizer Inc.) Company Details
Table 62. Hospira (Pfizer Inc.) Business Overview
Table 63. Hospira (Pfizer Inc.) Generic Injectable Drugs Product
Table 64. Hospira (Pfizer Inc.) Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 65. Hospira (Pfizer Inc.) Recent Developments
Table 66. Fresenius Kabi Company Details
Table 67. Fresenius Kabi Business Overview
Table 68. Fresenius Kabi Generic Injectable Drugs Product
Table 69. Fresenius Kabi Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 70. Fresenius Kabi Recent Developments
Table 71. Sandoz (Novartis) Company Details
Table 72. Sandoz (Novartis) Business Overview
Table 73. Sandoz (Novartis) Generic Injectable Drugs Product
Table 74. Sandoz (Novartis) Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 75. Sandoz (Novartis) Recent Developments
Table 76. Hikma Pharmaceuticals PLC Company Details
Table 77. Hikma Pharmaceuticals PLC Business Overview
Table 78. Hikma Pharmaceuticals PLC Generic Injectable Drugs Product
Table 79. Hikma Pharmaceuticals PLC Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 80. Hikma Pharmaceuticals PLC Recent Developments
Table 81. Dr. Reddy?s Laboratories Ltd Company Details
Table 82. Dr. Reddy?s Laboratories Ltd Business Overview
Table 83. Dr. Reddy?s Laboratories Ltd Generic Injectable Drugs Product
Table 84. Dr. Reddy?s Laboratories Ltd Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 85. Dr. Reddy?s Laboratories Ltd Recent Developments
Table 86. Grifols Company Details
Table 87. Grifols Business Overview
Table 88. Grifols Generic Injectable Drugs Product
Table 89. Grifols Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 90. Grifols Recent Developments
Table 91. Nichi-Iko Group (Sagent) Company Details
Table 92. Nichi-Iko Group (Sagent) Business Overview
Table 93. Nichi-Iko Group (Sagent) Generic Injectable Drugs Product
Table 94. Nichi-Iko Group (Sagent) Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 95. Nichi-Iko Group (Sagent) Recent Developments
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Generic Injectable Drugs Product
Table 99. Teva Pharmaceutical Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 100. Teva Pharmaceutical Recent Developments
Table 101. Auromedics Company Details
Table 102. Auromedics Business Overview
Table 103. Auromedics Generic Injectable Drugs Product
Table 104. Auromedics Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 105. Auromedics Recent Developments
Table 106. Sanofi Company Details
Table 107. Sanofi Business Overview
Table 108. Sanofi Generic Injectable Drugs Product
Table 109. Sanofi Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 110. Sanofi Recent Developments
Table 111. Gland Pharma Company Details
Table 112. Gland Pharma Business Overview
Table 113. Gland Pharma Generic Injectable Drugs Product
Table 114. Gland Pharma Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 115. Gland Pharma Recent Developments
Table 116. Endo International PLC Company Details
Table 117. Endo International PLC Business Overview
Table 118. Endo International PLC Generic Injectable Drugs Product
Table 119. Endo International PLC Revenue in Generic Injectable Drugs Business (2017-2022) & (US$ Million)
Table 120. Endo International PLC Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Injectable Drugs Market Share by Type: 2021 VS 2028
Figure 2. Small Molecule Features
Figure 3. Large Molecule Features
Figure 4. Global Generic Injectable Drugs Market Share by Application: 2021 VS 2028
Figure 5. Oncology Case Studies
Figure 6. Anesthesia Case Studies
Figure 7. Anti-Infectives Case Studies
Figure 8. Parenteral Nutrition Case Studies
Figure 9. Cardiovascular Diseases Case Studies
Figure 10. Generic Injectable Drugs Report Years Considered
Figure 11. Global Generic Injectable Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Generic Injectable Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Generic Injectable Drugs Market Share by Region: 2021 VS 2028
Figure 14. Global Generic Injectable Drugs Market Share by Players in 2021
Figure 15. Global Top Generic Injectable Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injectable Drugs as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Generic Injectable Drugs Revenue in 2021
Figure 17. North America Generic Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Generic Injectable Drugs Market Size Market Share by Type (2017-2028)
Figure 19. North America Generic Injectable Drugs Market Size Market Share by Application (2017-2028)
Figure 20. North America Generic Injectable Drugs Market Size Share by Country (2017-2028)
Figure 21. United States Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Generic Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Generic Injectable Drugs Market Size Market Share by Type (2017-2028)
Figure 25. Europe Generic Injectable Drugs Market Size Market Share by Application (2017-2028)
Figure 26. Europe Generic Injectable Drugs Market Size Share by Country (2017-2028)
Figure 27. Germany Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Generic Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Generic Injectable Drugs Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Generic Injectable Drugs Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Generic Injectable Drugs Market Size Share by Region (2017-2028)
Figure 37. China Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Latin America Generic Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Generic Injectable Drugs Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Generic Injectable Drugs Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Generic Injectable Drugs Market Size Share by Country (2017-2028)
Figure 47. Mexico Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Generic Injectable Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Generic Injectable Drugs Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Generic Injectable Drugs Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Generic Injectable Drugs Market Size Share by Country (2017-2028)
Figure 53. Turkey Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Generic Injectable Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Hospira (Pfizer Inc.) Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 57. Fresenius Kabi Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 58. Sandoz (Novartis) Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 59. Hikma Pharmaceuticals PLC Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 60. Dr. Reddy?s Laboratories Ltd Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 61. Grifols Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 62. Nichi-Iko Group (Sagent) Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 63. Teva Pharmaceutical Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 64. Auromedics Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 65. Sanofi Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 66. Gland Pharma Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 67. Endo International PLC Revenue Growth Rate in Generic Injectable Drugs Business (2017-2022)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Industry Market Size
